Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INFLUENZA B VIRUS - ANVISA Registration 81086830020

Access comprehensive regulatory information for INFLUENZA B VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81086830020 and manufactured by manufacturer not specified. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until Sep 14, 2030.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81086830020
2 Related Devices
Registration Details
ANVISA Registration Number: 81086830020
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

INFLUENZA B-CHECK-1
Risk Class III

Registration Details

81086830020

25351640951202019

20037992000139

Dates and Status

Sep 14, 2020

14/09/2030

09/18/2025 19:00:01

INFLUENZA B-CHECK-1
Risk Class III

Registration Details

81086830020

25351640951202019

20037992000139

Company Information

VEDALAB
France
PT: FRANÇA

Dates and Status

Sep 14, 2020

14/09/2030

09/18/2025 19:00:01